Sapatnekar, Aniruddha. “Conventional Synthetic Disease-Modifying Drugs Remain the Mainstay of Therapy for Rheumatoid Arthritis in India”. Journal of the Diabetic Association of India 1, no. 1 (May 2, 2025). Accessed July 17, 2025. https://journals.onemd.in/index.php/jdai/article/view/59.